Moderna has been chosen to be used for the inoculation of employees of South Korea’s top tech companies, including Samsung, LG, and SK Group. This information was revealed on Wednesday, June 9.
As per The Korea Herald, the S. Korean government has reserved Moderna COVID-19 vaccines for workers of major companies, and it is now preparing to distribute the vials to them in an effort to help businesses get back to normal operations as early as possible.
The inoculation for the leading firms in S. Korea
Based on the reports, the country’s Ministry of Employment and Labor already distributed a guide to firms on how the COVID-19 vaccine will be sent out and scheduled for their workers to receive the doses. Those that received the guide are Samsung Electronics, LG Group, and SK, also included in this guideline are the firms’ affiliates.
The guide was to allow the ministry to determine the amount of Moderna doses that the companies will need to have all of their workers inoculated. This vaccination program is said to be a strategic plan for industries that operate factories and have their own in-house clinics.
Since they have their own facilities, the vaccination will be easier since they can just get their schedules for the jab in their own clinics. It was revealed that the government may have to allocate more than 200,000 Moderna shots as in Samsung Electronics alone, it needs about 100,000 vaccine doses already.
“Employees who want to get the Moderna shots were told to submit applications,” an industry insider told the media outlet. “However, there is no confirmed administration schedule yet.”
For SK and LG, they are confirmed for Moderna jabs too and were already contacted by the government as well. "SK Hynix is considering measures to follow the government guideline regarding the vaccination," a company official stated.
S.Korea approves Moderna vaccine
Meanwhile, South Korea approved Moderna vaccines only last month, as per Reuters. The nation’s drug safety minister Kim Gang Lip confirmed that the American version of the COVID-19 vaccine was greenlighted in an effort to speed up the vaccinations.
Finally, it was revealed that three experts have participated in the Moderna review, and they recommended for the shots to be approved for two-dose inoculations.


Japan Economy Minister Downplays Inflation Risks Despite BOJ Warning
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Gold Price Hits Seven-Week High as Fed Rate Hike Bets Fade and Hormuz Deal Hopes Grow
Asian Stocks Slip as AI Rally Fades, Oil Holds Steady on Iran Peace Deal Hopes
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Asian Stocks Slide as Semiconductor Selloff Weighs on South Korea and Japan
Oil Prices Slip as Hormuz Shipping Progress and Rising U.S. Crude Stocks Weigh on Market
Australia Trade Surplus Returns in June as Iron Ore, Coal and LNG Exports Surge
Oil Prices Extend Three-Day Decline as Hopes Rise for U.S.-Iran Strait of Hormuz Deal
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Wall Street Ends Mixed as Dow Hits Record Despite Tech Weakness
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Indonesia Q2 2026 GDP Growth Beats Forecast Despite Market Concerns
Brazil Cuts Selic Rate to 14% as Inflation Eases but Risks Persist
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing
RBI Holds Repo Rate at 5.25% as Inflation Risks and Global Uncertainty Persist 



